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OBJECTIVE: Our objective was to evaluate the effects of small-volume, home-based exercise combined with
slight caloric restriction on the inflammatory markers C-reactive protein and adiponectin.
METHODS: In total, 54 women were randomly assigned to one of two groups for exercise intervention: the
control or home-based exercise groups. Weight, waist and hip circumferences, and inflammatory markers were
measured at baseline and after 6 and 12 months. Women allocated to the home-based exercise group received
a booklet explaining the physical exercises to be practiced at home at least 3 times per week, 40 minutes per
session, at low-to-moderate intensity. All participants received dietary counseling aimed at reducing caloric
intake by 100-300 calories per day, with a normal distribution of macro-nutrients (26-28% of energy as fat).
Clinicaltrials.gov: NCT01206413
RESULTS: The home-based exercise group showed a significantly greater reduction in weight and body mass
index at six months, but no difference between groups was observed thereafter. With regard to the
inflammatory markers, a greater but non-statistically significant reduction was found for C-reactive protein in
the home-based exercise group at six months; however, this difference disappeared after adjusting for weight
change. No differences in adiponectin were found at the 6- or 12-month follow-up.
CONCLUSION: Small-volume, home-based exercise did not promote changes in inflammatory markers
independent of weight change.
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& INTRODUCTION
Obesity is considered to be a state of chronic, low-grade
inflammation in which a greater production of pro-
inflammatory cytokines overcomes the production of
cytokines with anti-inflammatory properties. This condition
seems to be involved in the pathogenesis of insulin
resistance and vascular injury among obese individuals,
predisposing those who gain weight to a greater risk of
developing type 2 diabetes and cardiovascular diseases
(1-3). C-reactive protein (CRP), which is secreted by liver
cells, is a well-recognized clinical marker of inflammation
that has been implicated in the pathogenesis of many
chronic diseases. Large cross-sectional studies have shown
that elevated serum levels of CRP are associated with
increased body weight (4,5). In contrast, adiponectin is a
protein secreted in abundance by adipose tissue in healthy
subjects and possesses insulin-sensitizing, anti-inflamma-
tory, and anti-atherogenic properties (6). Adiponectin levels
are reduced in conditions such as obesity, type 2 diabetes,
metabolic syndrome, and ischemic heart disease (7,8).
Lifestyle interventions focusing on the prevention of
weight gain, including physical activity, are an important
method of curbing the increasing prevalence of obesity and
its complications (9,10). Although many studies have
demonstrated the beneficial effects of exercise on anthro-
pometric and metabolic parameters, the effects of exercise
on the state of chronic, low-grade inflammation remain
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controversial (11-14). The results of cross-sectional studies
indicate an important association between high levels of
physical activity, low levels of CRP, and increased total
adiponectin (15,16). A large longitudinal study of 3,042
individuals (1,524 men and 1,518 women), without any
evidence of cardiovascular risk, evaluated the relationship
between self-reported physical activity status and serum
inflammatory markers and showed that participants
devoted to high physical activity (.7 kcal/min expended)
had a 29% lower concentration of C-reactive protein
compared with those who were sedentary, even after
adjusting for several confounders, such as gender, age,
smoking habits, body mass index, total cholesterol, glucose,
and blood pressure (17). Moreover, a cross-sectional study
conducted by Tsukinoki et al. (18) investigating the
associations between lifestyle factors (including physical
activity levels) and plasma adiponectin levels among 202
Japanese male workers showed that even after adjustments
for potential confounders, exercising two or more times per
week significantly decreased the risk of low adiponectin
levels (OR= 0.21; 95% CI = 0.06-0.74).
In contrast, the results from clinical trials that examined
the effects of exercise on low-grade inflammation are far
from conclusive, with some studies showing the beneficial
effects of exercise related to weight loss, others showing
beneficial effects independently of weight loss, and still
others showing no effect for exercise. It is noteworthy that
most of these results were observed in obese individuals
with high inflammatory levels at baseline (19-23). The
degree of obesity may complicate the evaluation of exercise
per se on inflammatory markers.
An important aspect related to the practice of physical
activity is the low adherence to formal programs (24), which
limits the efficacy of this intervention and highlights the
need to identify strategies to promote an increased
adherence to physical exercise. In this context, home-based
exercise programs could emerge as an important and
feasible strategy to prevent weight gain because it is low
cost and less time-consuming . Some authors have shown
positive effects of this intervention on different types of
outcomes (25,26). Additionally, the prescribed amount of
exercise may be of paramount importance to exercise
adherence, with more demanding exercise programs asso-
ciated with poorer adherence (27).
Therefore, we designed a study based on a small-changes
approach (28) in which a small volume and low-to-moderate
intensity home-based exercise program improves exercise
adherence and subsequently promote greater health benefits.
The main results of the present trial related to weight change
and lipids have already been published (29). In the present
analysis, we randomly selected a subgroup of blood speci-
mens from our previous participants to evaluate the effects of
small-volume, home-based exercise combined with slight
caloric restriction on C-reactive protein and total adiponectin.
Our study, conducted in a more homogeneous group of non-
obese women, may aid us in evaluating the effect of exercise
on inflammation.
& MATERIALS AND METHODS
The study population consisted of a sub-sample of a
randomized clinical trial aimed at evaluating the effects of
home-based exercise on weight change among non-obese
women over a 12-month period. The full description and
results of the effects of exercise intervention on anthropo-
metric measures have been published elsewhere (29).
Briefly, 203 healthy women aged 25-45 years with a body
mass index (BMI) of 23-29.9 kg/m2 and who were not
pregnant or breastfeeding, had at least one child, and did
not practice regular physical activity at least 6 months prior
the study were randomly assigned to one of two groups for
exercise intervention: the control (CG) or home-based (HB)
exercise groups. All participants were fully informed about
the objectives of the study and signed an informed consent
form to participate. The study was approved by the
Institutional Review Board of the State University of Rio
de Janeiro.
In the present analysis, we included a total of 54 women
(CG=28 and HB=26) from whom blood samples were
collected at baseline and 6 and 12 months of follow-up. The
sample size required to detect a difference of 1.2 mg/L for
C-reactive protein with a standard deviation of 0.97 mg/L,
assuming a power of 90% and a significance level of 5%, was
30 women. Allowing for non-compliance in both groups, the
estimated sample size was 50 (25 for each group).
Measurements
Weight, waist and hip circumferences, and inflammatory
markers were measured at baseline and after 6 and 12
months of follow-up. Height was measured to the nearest
0.5 cm with a wall-mounted stadiometer, and body weight
was measured using the same calibrated digital scale for all
participants. Circumferences were determined with the
participants standing and were measured at the largest
girth of the hip and at the smallest girth of the waist. All
measurements were performed in the morning, and blood
samples were collected after a 10-hour fast. Aliquots of
plasma and serum were isolated from the blood samples
and frozen at -70 C˚ within 2 h of being drawn.
The CRP concentration was determined using an enzyme
immunoassay kit for humans according to themanufacturer’s
instructions (Human PCR Enzyme-linked Immunosorbent
Assay Kit, USCN Life Science Inc., P.R., China). The kit had
an assay sensitivity of 0.059 ng/mL and an intra-assay
variation coefficient of 3.75%. Total serum adiponectin was
determined using a commercial radioimmunoassay kit
(Human Adiponectin RIA KIT I125 coated tube, Millipore
Corporation, MA, USA) with an assay sensitivity of 1 ng/mL
and an intra-assay variation coefficient of 8.54%.
Intervention
Women allocated to the HB group were counseled by an
exercise physiologist during the first appointment who
explained in detail all the exercises to be practiced at home
at least 3 times per week for 40 minutes per session (the
booklet is available at www.nebin.org). In the first week,
women were advised to perform only one 20-minute
session, increasing gradually (10 minutes/session/week)
up to 40 minutes per session. The participants were asked
to maintain an exercise intensity that allowed the partici-
pant to talk with any person next to them without
breathlessness (low-to-moderate intensity) if necessary
(30). The exercise sessions were divided into three parts:
1) a warm-up routine consisting of gentle body movements
and stretching exercises (5 minutes); 2) an aerobic cycle
performed in a circuit with continuous movements invol-
ving the large arm and leg muscles, as well as exercises
using a ball and ropes, stair climbing, and standing up
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from a chair (30 minutes; balls and ropes were provided to
the participants); and 3) a cool-down period during which
the same initial stretching exercises were performed (5
minutes). Compliance with the exercise program was
assessed once per month during the counseling sessions
by having the women mark the days on which they
exercised on a specific card printed with the days of the
week. At this time, possible doubts related to the exercise
program were clarified. The control group received only
general information about the benefits of physical activity;
no formal exercise prescription was provided to this group.
Both groups received dietary counseling aimed at reducing
their caloric intake by 100-300 calories per day, with a
normal distribution of macro-nutrients (26-28% of energy
as fat).
Data analysis
The baseline characteristics of the two groups were
compared using Student’s t-test. Baseline correlations
between anthropometric measures, CRP, and total adiponec-
tin were estimated using the Spearman’s correlation coeffi-
cient. Temporal changes in the anthropometric and
inflammatory markers between groups were assessed by
repeated random regression analysis using the procedure
PROC MIXED in SAS (version 9.1, SAS Institute Inc, Cary,
NC, USA). The analysis of anthropometric measures
included BMI at baseline as a covariate, whereas the baseline
measures were included for CRP and total adiponectin.
Because of the non-linear weight change observed, the model
incorporated a quadratic term (time6time) variable. The term
of interest was time6treatment interaction, which estimates
the rate of change in the outcomes. Statistical significance was
set at p,0.05 for all analyses.
& RESULTS
No differences between the control and exercise groups
were found in the baseline characteristics except for age,
which showed a small difference (39.4¡4.7 and 36.9¡5.5,
respectively; p= 0.08), and CRP, which showed a statistically
significant difference (0.68¡0.32 vs. 0.99¡0.54, respectively;
p= 0.01). As expected, the Spearman’s correlation coefficient
between anthropometric measurements, CRP, and total
adiponectin at baseline showed that CRP was significantly
associated with body weight (r = 0.30; p= 0.05) and BMI
(r = 0.30; p= 0.04), whereas adiponectin was significantly
inversely associated with the waist-to-hip ratio (r = -0.30;
p= 0.03).
During follow-up, the HB group showed a greater
reduction in weight (-1.71 vs. -0.50; p= 0.03) and BMI (-0.67
vs. -0.20; p= 0.03) at six months. Thereafter, no differences
between the groups were observed in these parameters
(Table 1). For the inflammatory markers, a greater but non-
statistically significant reduction was found for CRP in the
HB group at six months (-0.03 vs. 0.15; p= 0.09), but this
difference disappeared after adjusting for weight change
(p= 0.30). Additionally, no differences were found for total
adiponectin during the 12 months of follow-up (Table 1).
The main changes in CRP and adiponectin during the 12
months of follow-up are shown in Figure 1. The compliance
rates with the exercise protocol during the follow-up period
were 79 and 80% for months 6 and 12, respectively.
& DISCUSSION
The present study demonstrated that a small volume of
home-based exercise did not promote changes in either CRP
or total adiponectin levels and highlights the importance of
weight loss for the reduction of CRP, independently of
physical activity, even among non-obese women. A greater
reduction in CRP was observed among exercisers at 6
months of follow-up; however, this difference was not
maintained when weight was regained after 6 months, and
the borderline association disappeared when the analysis of
CRP change at 6 months was adjusted for weight change.
Table 1 - Crude means (standard deviation) and adjusted changes from baseline (D) for anthropometric measurements
and inflammatory markers during the follow-up by intervention group (controls = 28 and home-based exercise = 26).
Baseline p-valuea 6 months p-valueb 12 months p-valueb
Mean(sd) Mean(sd) D Mean(sd) D
Body Weight (kg)
Control 65.6 (6.5) 0.12 64.4 (7.3) -0.50 0.03 63.2 (5.9) -1.50 0.16
Intervention 68.6 (7.6) 67.1 (9.5) -1.71 65.7 (6.9) -1.88
Body Mass Index (kg/m2)
Control 25.8 (1.8) 0.08 25.5 (2.1) -0.20 0.03 25.1 (2.1) -0.57 0.18
Intervention 26.7 (1.9) 26.1 (2.1) -0.67 25.8 (2.2) -0.76
Waist Circumference (cm)
Control 80.5 (4.8) 0.19 79.3 (5.6) -0.74 0.56 79.3 (3.9) -1.28 0.75
Intervention 82.4 (5.4) 79.8 (5.3) -1.23 81.9 (3.2) -1.68
Waist-to-hip Ratio
Control 0.79 (0.05) 0.68 0.79 (0.05) 0.003 0.60 0.77 (0.02) 0.009 0.17
Intervention 0.79 (0.05) 0.77 (0.05) -0.0005 0.80 (0.05) -0.004
C-reactive Protein (mg/L)
Control 0.68 (0.32) 0.01 0.83 (0.38) 0.15 0.09 0.80 (0.33) 0.15 0.37
Intervention 0.99 (0.54) 0.96 (0.42) -0.03 1.01 (0.38) 0.007
Adiponectin (mg/L)
Control 12.40 (6.40) 0.76 16.28 (24.90) -1.33 0.94 16.41 (15.21) 3.58 0.93
Intervention 11.61 (9.98) 10.20 (4.87) -1.46 15.57 (13.30) 3.75
aStudent’s t-test.
bRepeated random regression analysis; the model included time, treatment, and the time6treatment interaction adjusted for baseline values (PROC
MIXED, SAS 9.1).
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The importance of weight loss in CRP changes has been
observed in many studies using different types of interven-
tions, including physical activity (31,32). A randomized
controlled trial conducted by Campbell et al. (33) evaluated
the effects of a year-long moderate-intensity aerobic exercise
program (60-75% maximal HR, 40 minutes per session, 3
days per week) on CRP in 115 overweight or obese
postmenopausal women. There was a statistically signifi-
cant reduction in CRP among exercisers compared with
controls (-0.24 vs. 0.29; p = 0.01), with better results obtained
in those women who were obese at baseline and lost a
greater amount of weight. In addition, only those exercisers
who decreased their body fat by 2% or greater experienced a
statistically significant reduction in CRP versus controls,
suggesting that the exercise effect was primarily dependent
on fat loss. In another randomized controlled trial, Church
et al. (34) observed no effect of exercise training without
weight loss on the reduction of CRP when studying
individuals with a BMI between 18.5 and 40 kg/m2 and
elevated CRP at baseline ($2.0 mg/L). The authors found a
correlation between weight loss and reduction in CRP after
4 months of follow-up (r = 0.18; p,0.05). Moreover, Fisher
et al. (35) examined the effects of three different intervention
groups (diet only, diet plus aerobic training, and diet plus
resistance training) on CRP among premenopausal over-
weight women until they reached a BMI ,25 kg/m2 and
demonstrated a significant reduction in plasma CRP in all
three intervention groups at the final follow-up, with no
differences in CRP among the groups. This finding suggests
that independently of the type of intervention, weight loss
had a more profound impact on the reduction of CRP in
overweight women than exercise per se.
Despite the importance of weight change in improve-
ments in CRP, some other studies have suggested that
exercise could reduce CRP even in the absence of weight
loss (36,37). For instance, Donges et al. (38) conducted a
clinical trial to investigate the effects of two different
exercise interventions (resistance vs. aerobic exercise) on
inflammatory markers during 10 weeks of follow-up and
found an important reduction in CRP among the resistance
exercise group even without changes in anthropometric
measures, suggesting that reductions in inflammatory
markers do not necessarily need to occur in the presence
of weight loss or changes in body composition. In another
study, Balducci et al. (39) examined the effect of different
exercise modalities on circulating levels of inflammatory
markers, including CRP, among 82 individuals with
metabolic syndrome (BMI 27-40 kg/m2) randomized into
Figure 1 - Estimated changes for CRP and adiponectin during the 12 months of follow-up by intervention groups.
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four groups: (1) sedentary controls, (2) those receiving
counseling to perform low-intensity physical activities, (3)
those performing prescribed and supervised high-intensity
aerobic exercise, and (4) those performing high-intensity
aerobic exercise plus resistance training. Although no
significant changes in body weight, BMI, fat, or fat-free
mass were observed in any of the groups, the levels of CRP
decreased in all three exercise groups, with a greater
reduction found in those who performed aerobic plus
resistance exercise after 12 months of follow-up (54%
reduction from baseline). A multiple regression analysis
showed that maximum oxygen consumption, exercise
volume, and the type of exercise were independent
predictors of changes in CRP levels, and the authors
suggested that factors related to the exercise prescription,
such as type, volume, and intensity of the exercise, could
contribute more to improvements in CRP than weight loss.
Regarding the effects of exercise on adiponectin, the
exercise intervention proposed in the present study did not
change the levels of this cytokine during the 12 months of
follow-up, although some other studies have demonstrated
the positive effects of exercise (40,41). Kriketos et al. (42)
demonstrated a substantial increase in adiponectin levels
(approximately 260%) after 10 weeks of aerobic exercises
performed 4-5 days per week for 40 minutes per session at
moderate intensity (55-70% VO2 max) in overweight
individuals. This result was corroborated by the findings
of Yoshida et al. (43), revealing that an increase of 51% in
adiponectin values was observed after 16 weeks of
moderate-intensity exercise (60-80% of age-predicted max-
imal heart rate) performed 2-3 times per week for 60
minutes per session in normal-weight dyslipidemic indivi-
duals.
A systematic review conducted by Simpson & Singh (21),
which included a total of eight randomized clinical trials
evaluating the effects of exercise on adiponectin, showed a
significant increase in plasma adiponectin ranging from 4.7-
34.0% across studies, with an average increase of 16.3%, in
response to different exercise modalities ranging from
moderate to high intensities. The authors suggested that a
minimum exercise volume of 90 minutes per week appeared
to be necessary to achieve significant increases in adipo-
nectin levels, and a possible dose-response effect of intensity
has been observed in some studies (44).
Polak et al. (45) examined the effects of low-intensity
aerobic exercise (50% VO2 max) performed 5 days per week
for 12 weeks among 25 obese sedentary premenopausal
women and found no changes in adiponectin levels even in
the presence of significant decreases in body weight and fat
mass of 5.9 and 6.5% (p,0.001), respectively. Conversely, a
study conducted by Moghadasi et al. (46) demonstrated that
a high-intensity endurance exercise program (75-80% VO2
max) performed 4 days a week for 12 weeks increased
plasma adiponectin concentrations and gene expression of
this cytokine in middle-aged men, reinforcing the impor-
tance of exercise intensity in inflammatory marker changes.
However, it is important to note that, in the aforementioned
study, a decrease in body weight was also found. The
authors stated that exercise-induced changes in body weight
and fat mass may play a pivotal role in improving plasma
adiponectin, as previously shown by Marcell et al. (47), who
observed that a greater reduction in body weight and fat
mass promoted greater improvements in adiponectin levels.
The lack of a significant effect of exercise on CRP and
adiponectin in the present study may indicate that our
exercise protocol may have been insufficient in terms of the
intensity and volume of training required to promote the
physiological adaptations necessary to improve these
markers. We could speculate that low-intensity exercises,
such as those promoted by our study, need to lead to greater
weight loss to reduce CRP and increase adiponectin,
whereas higher intensity exercises seem to promote changes
in inflammatory markers independently of weight loss. A
systematic review conducted by Hamer (48) concluded that
both fitness and fatness are associated with systemic
inflammatory status and that contributions of both may
depend on several factors, such as age, gender, disease, and
degree of inflammation at baseline. For example, exercise
training is more effective among those individuals with high
CRP and low adiponectin values (49,50), a situation that did
not occur in our study because none of the participants
showed high CRP values (.3.0 mg/L) (51) and only one
woman demonstrated low adiponectin levels (,4.0 mg/L)
(52) at baseline.
Another important result of the present study corre-
sponds to the baseline correlations between anthropometric
measures, CRP, and total adiponectin. CRP was correlated
with BMI and body weight, whereas adiponectin was
associated with waist-to-hip ratio, a surrogate of central
adiposity. These data suggest that total body fat is more
important for the determination of CRP levels, whereas
abdominal fat seems to be of central importance to
adiponectin levels, confirming the findings demonstrated
previously by other authors (53-55).
The limitations of the present study include the lack of a
gold standard measure of physical activity, although a self-
reported diary shows good correlation with other methods,
such as accelerometers and double-labeled water (56,57). In
addition, the inflammatory marker used in the present
study (CRP) can be highly variable and can be affected by
numerous factors, such as the menstrual cycle, drugs, and
alcohol consumption (58-60). Due to our small sample size,
it was not possible to perform a sub-group analysis
separating overweight from normal-weight women, shifting
our findings toward the null hypothesis. Moreover, the
subjects in the present study consisted only of females who
were not obese, making it difficult to extrapolate the results
to males and obese individuals.
In conclusion, a small-volume, home-based exercise
program did not promote changes in inflammatory markers
after 6 and 12 months of follow-up among non-obese
women. The greatest reduction in CRP observed among
those women who performed exercise after six months was
primarily caused by weight loss. Comparisons of the effects
of different exercise modalities, as well as different volumes
and intensities of training, on inflammatory markers and the
relationship with weight change could be an important
topic for future research.
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